Literature DB >> 31530117

Koro Delusion in Mild Cognitive Impairment Due to Alzheimer's Disease.

Michael Tau1, Arjun V Masurkar1.   

Abstract

Entities:  

Keywords:  Alzheimer’s Disease; Delusion; Psychosis

Year:  2019        PMID： 31530117      PMCID： PMC7147812          DOI： 10.1176/appi.neuropsych.19050108

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  25 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  KORO--A CULTURE-BOUND DEPERSONALIZATION SYNDROME.

Authors:  P M YAP
Journal:  Br J Psychiatry       Date:  1965-01       Impact factor: 9.319

3.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Koro syndrome associated with alcohol-induced systemic disease in a Zulu.

Authors:  T J Holden
Journal:  Br J Psychiatry       Date:  1987-11       Impact factor: 9.319

5.  Koro secondary to a tumour of the corpus callosum.

Authors:  R Durst; P Rosca-Rebaudengo
Journal:  Br J Psychiatry       Date:  1988-08       Impact factor: 9.319

6.  Koro: computed tomography and brain electrical activity mapping in two patients.

Authors:  A B Joseph
Journal:  J Clin Psychiatry       Date:  1986-08       Impact factor: 4.384

7.  Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.

Authors:  Fernando E Taragano; Ricardo F Allegri; Silvina L Heisecke; María I Martelli; Mónica L Feldman; Viviana Sánchez; Virginia A García; Graciela Tufro; Diego M Castro; Patricio Perez Leguizamón; Verónica Guelar; Eva Ruotolo; Cecilia Zegarra; Carol Dillon
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  The nature of psychotic symptoms in senile dementia of the Alzheimer type.

Authors:  E H Rubin; W C Drevets; W J Burke
Journal:  J Geriatr Psychiatry Neurol       Date:  1988-01       Impact factor: 2.680

Review 9.  A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

Authors:  Roberto Monastero; Francesca Mangialasche; Cecilia Camarda; Sara Ercolani; Rosolino Camarda
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 10.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.